Medical Research Council-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Medical Research Council-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH204321D
  • |
  • Pages: 61
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Medical Research Council (MRC) is a research organization that provides services to improve human health through medical research. The council offers research across medical sciences services, universities and hospitals, centers and institutes. It provides fellowships and studentships programs. MRC also provides data management, research platform, tools and facilities to generate mouse models of human disease for researchers. The council has funded various research programs, which include experimental medicine, informatics, lifelong health and wellbeing, obesity research, population health sciences, regenerative medicine and stem cells and stratified medicine, among others. It also funds for researches on stem cells. MRC is headquartered in Swindon, the UK.

Medical Research Council-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Medical Research Council, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Medical Research Council, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Medical Research Council, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Medical Research Council, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Medical Research Council, Medical Devices Deals, 2011 to YTD 2017 10

Medical Research Council, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Medical Research Council, Pharmaceuticals & Healthcare, Deal Details 14

Partnerships 14

MRC Technology, UCB and University of Leicester Enter into Agreement 14

MRC Technology Enters into Co-Development Agreement with IPS-CAS 15

MRC Technology Partners with University of Lausanne 15

MRC Technology Enters into Agreement with Peptinnovate 16

MRC Technology Enters into Co-Development Agreement with NYU School of Medicine 16

MRC Technology Enters into Co-Development Agreement with Proximagen 17

AstraZeneca Extends its Co-Development Agreement with MRC 18

AstraZeneca Extends Collaboration with MRC Technology 19

MRC Technology Enters into Drug Discovery Agreement with Daiichi Sankyo 20

AstraZeneca Enters Into Drug Discovery Agreement With Medical Research Council 21

MRC Technology Enters Into Co-Development Agreement With Oxford University 22

MRC Technology Enters Into Co-Development Agreement With Boston University 23

MRC Technology Enters Into Agreement With EMBL Enterprise Management For Drug Development 24

MRC Technology Enters Into Co-Development Agreement With Institute of Biophysics Chinese Academy of Sciences 24

MRC Technology Enters Into Drug Discovery Agreement With Chinese Academy of Sciences 25

Enamine Enters Into Co-Development Agreement With MRC LMB And IOCB For Rhomboid Protease Inhibitors 26

MRC Technology Enters Into Drug Discovery Agreement With Queen Mary University 27

MRC Technology Enters Into Second Research Agreement With University of Bristol 28

Mount Sinai School of Medicine Enters Into Co-Development Agreement With MRC Technology 29

MRC Technology Enters Into Agreement With University of Bristol To Develop TrkA Antagonists 30

MRC Technology Enters Into Co-Development Agreement With University Of Aberdeen 31

Medical Research Council, Imperial College, King's College and UCL Form Joint Venture 31

Imperial College London, King's College London, University College London, Medical Research Council And GSK Form Joint Venture 32

Licensing Agreements 34

Shanghai Newsummit Biopharma Enters into Licensing Agreement with MRC Technology 34

Georg-August-University Gottingen Enters into Licensing Agreement with MRC Technology 34

MBM ScienceBridge, Georg-August-University Gottingen, University Medical Center Gottingen and MRC Technology, Enter into Licensing Agreement 35

Yabao Pharma Enters into Licensing Agreement with MRC Technology 36

Bio-Techne Enters into Licensing Agreement with MRC for Protein Synthesis Technology 37

UCB Enters Into Licensing Agreement With Medical Research Council Technology For Fibrosis Program 38

Cambridge Research Biochemicals Enters Into Licensing Agreement With Medical Research Council 39

Phosphate Therapeutics Enters Into Licensing Agreement With Medical Research Council For PT20 40

Asset Transactions 41

Pfizer Acquires Melanocortin Receptors from MRC Technology 41

Medical Research Council-Key Competitors 43

Key Employees 44

Locations And Subsidiaries 45

Head Office 45

Other Locations & Subsidiaries 45

Recent Developments 47

Government and Public Interest 47

Mar 17, 2017: Oxford BioDynamics announces collaboration to identify biological factors that trigger disease relapses in Rheumatoid Arthritis 47

Mar 02, 2017: Abzena, UCL secure GBP3.5m grant from MRC for autoimmune therapy research 48

Jan 25, 2017: Zika virus, superbugs and arthritis targeted through GBP26 million fund 49

Aug 31, 2016: Accumulation of a product of cell metabolism found to be linked with kidney tumour growth 50

May 19, 2016: MRC announces cross-council awards worth nearly GBP10m to tackle antibiotic resistance 51

May 17, 2016: Psilocybin for treatment-resistant depression 53

Apr 26, 2016: Potential cause of dementia to be investigated with GBP1m grant 55

Feb 16, 2016: Gene could help identify psychosis risk in cannabis users 56

Feb 15, 2016: Cutting edge medical research ideas receive GBP23.2m boost 57

Feb 11, 2016: Blocking stress protein relieves chronic pain in mice 58

Feb 03, 2016: MRC launches Rapid Response to fast-track Zika research 59

Jan 27, 2016: Study finds paracetamol use in pregnancy can cut female fertility 60

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61

List of Figures

Medical Research Council, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Medical Research Council, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Medical Research Council, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Medical Research Council, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Medical Research Council, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Medical Research Council, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Medical Research Council, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Medical Research Council, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Medical Research Council, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

Medical Research Council, Pharmaceuticals & Healthcare, Key Facts 1

Medical Research Council, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Medical Research Council, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Medical Research Council, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Medical Research Council, Deals By Therapy Area, 2011 to YTD 2017 9

Medical Research Council, Medical Devices Deals, 2011 to YTD 2017 10

Medical Research Council, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

MRC Technology, UCB and University of Leicester Enter into Agreement 14

MRC Technology Enters into Co-Development Agreement with IPS-CAS 15

MRC Technology Partners with University of Lausanne 15

MRC Technology Enters into Agreement with Peptinnovate 16

MRC Technology Enters into Co-Development Agreement with NYU School of Medicine 16

MRC Technology Enters into Co-Development Agreement with Proximagen 17

AstraZeneca Extends its Co-Development Agreement with MRC 18

AstraZeneca Extends Collaboration with MRC Technology 19

MRC Technology Enters into Drug Discovery Agreement with Daiichi Sankyo 20

AstraZeneca Enters Into Drug Discovery Agreement With Medical Research Council 21

MRC Technology Enters Into Co-Development Agreement With Oxford University 22

MRC Technology Enters Into Co-Development Agreement With Boston University 23

MRC Technology Enters Into Agreement With EMBL Enterprise Management For Drug Development 24

MRC Technology Enters Into Co-Development Agreement With Institute of Biophysics Chinese Academy of Sciences 24

MRC Technology Enters Into Drug Discovery Agreement With Chinese Academy of Sciences 25

Enamine Enters Into Co-Development Agreement With MRC LMB And IOCB For Rhomboid Protease Inhibitors 26

MRC Technology Enters Into Drug Discovery Agreement With Queen Mary University 27

MRC Technology Enters Into Second Research Agreement With University of Bristol 28

Mount Sinai School of Medicine Enters Into Co-Development Agreement With MRC Technology 29

MRC Technology Enters Into Agreement With University of Bristol To Develop TrkA Antagonists 30

MRC Technology Enters Into Co-Development Agreement With University Of Aberdeen 31

Medical Research Council, Imperial College, King's College and UCL Form Joint Venture 31

Imperial College London, King's College London, University College London, Medical Research Council And GSK Form Joint Venture 32

Shanghai Newsummit Biopharma Enters into Licensing Agreement with MRC Technology 34

Georg-August-University Gottingen Enters into Licensing Agreement with MRC Technology 34

MBM ScienceBridge, Georg-August-University Gottingen, University Medical Center Gottingen and MRC Technology, Enter into Licensing Agreement 35

Yabao Pharma Enters into Licensing Agreement with MRC Technology 36

Bio-Techne Enters into Licensing Agreement with MRC for Protein Synthesis Technology 37

UCB Enters Into Licensing Agreement With Medical Research Council Technology For Fibrosis Program 38

Cambridge Research Biochemicals Enters Into Licensing Agreement With Medical Research Council 39

Phosphate Therapeutics Enters Into Licensing Agreement With Medical Research Council For PT20 40

Pfizer Acquires Melanocortin Receptors from MRC Technology 41

Medical Research Council, Key Competitors 43

Medical Research Council, Key Employees 44

Medical Research Council, Other Locations 45

Medical Research Council, Subsidiaries 45

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Medical Research Council, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16120
Site License
USD 500 INR 32240
Corporate User License
USD 750 INR 48360

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com